Photo from Liang Cheng/LinkedIn
Aug 9, 2024, 12:32
Liang Cheng: Applications of AI in Prostate Cancer management
Liang Cheng, Vice Chair for Translational Research at The Warren Alpert Medical School of Brown University, shared on LinkedIn a recent paper by Lingxuan Zhu et al. titled “Harnessing artificial intelligence for prostate cancer management” published in Cell Reports Medicine.
Authors: Lingxuan Zhu, Jiahua Pan, Weiming Mou, Liang Cheng, Rui Chen, Wei Xue et al.
“I am pleased to share this State-of-the Art Review ‘Harnessing artificial intelligence for prostate cancer management’ published in Cell Reports Medicine. Great honor to be part of the team!
Take home message:
- This review provides an overview of the current developments and applications of AI in Prostate Cancer management. One promising direction for future research is to predict molecular subtype based on pathology images or combining it with other omics techniques for precise diagnosis and treatment recommendations.
- Generative AI tools such as ChatGPT hold promise for clinical implementation. Drawing from its success in other fields, tools such as ChatGPT can be fine-tuned for specific tasks in Prostate cancer management, such as simplifying pathology reports for patient understanding.
- Integrating patient histories with WSIs for diagnosis and treatment recommendations is also feasible with updated multimodal analysis capabilities. However, careful evaluation is necessary to avoid hype.”
Source: Liang Cheng/LinkedIn
More posts by Liang Cheng in OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14